Form 483

Aveva Drug Delivery Systems Inc. Form 483, 2014-04-11

FDA issued a Form 483 to Aveva Drug Delivery Systems Inc. on 2014-04-11 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

Aveva Drug Delivery Systems Inc. · Miramar, United States · Issued April 11, 2014

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Apr 2014
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Jessica L Pressley, Ileana Barreto-Pettit

11 Apr 2014
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Jessica L Pressley, Ileana Barreto-Pettit

11 Apr 2014
21 CFR 211.68(b)

Computer control of master formula records

Cited by Jessica L Pressley, Ileana Barreto-Pettit

11 Apr 2014
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Jessica L Pressley, Ileana Barreto-Pettit

11 Apr 2014
21 CFR 211.130

Procedures are written, and followed

Cited by Jessica L Pressley, Ileana Barreto-Pettit

Inspected site

ADAveva Drug Delivery Systems Inc.Miramar, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.130Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere